Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Qiagen NV’s stock clocked out at $48.86, down -0.08% from its previous closing price of $48.9. In other words, the price has decreased by -$0.08 from its previous closing price. On the day, 1.06 million shares were traded. QGEN stock price reached its highest trading level at $49.28 during the session, while it also had its lowest trading level at $48.78.
Ratios:
To gain a deeper understanding of QGEN’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 11.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.22. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on June 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
Robert W. Baird Downgraded its Outperform to Neutral on February 19, 2025, whereas the target price for the stock was revised from $52 to $42.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’25 when Thierry Bernard bought 25,000 shares for $48.80 per share.
ROLAND SACKERS bought 31,423 shares of QGEN for $1,546,257 on Aug 15 ’25. On Aug 14 ’25, another insider, ROLAND SACKERS, who serves as the Officer of the company, bought 18,577 shares for $49.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 10594509824 and an Enterprise Value of 11132622848. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.60, and their Forward P/E ratio for the next fiscal year is 19.29. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.19 while its Price-to-Book (P/B) ratio in mrq is 3.02. Its current Enterprise Value per Revenue stands at 5.457 whereas that against EBITDA is 11.158.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.65, which has changed by 0.06657934 over the last 52 weeks, in comparison to a change of 0.15624678 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $51.88, while it has fallen to a 52-week low of $37.63. The 50-Day Moving Average of the stock is 0.39%, while the 200-Day Moving Average is calculated to be 10.73%.
Shares Statistics:
It appears that QGEN traded 1.43M shares on average per day over the past three months and 988200 shares per day over the past ten days. A total of 216.83M shares are outstanding, with a floating share count of 214.83M. Insiders hold about 0.80% of the company’s shares, while institutions hold 78.55% stake in the company. Shares short for QGEN as of 1753920000 were 6598386 with a Short Ratio of 4.62, compared to 1751241600 on 5391139. Therefore, it implies a Short% of Shares Outstanding of 6598386 and a Short% of Float of 4.52.
Dividends & Splits
With its trailing 12-month dividend rate of 0.25, QGEN has a forward annual dividend rate of 0.25. Against a Trailing Annual Dividend Yield of 0.0051124743The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2025-07-02 with an ex-dividend date of 2025-07-02. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
Earnings Estimates
The current assessment of Qiagen NV (QGEN) involves the perspectives of 11.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $0.61, with high estimates of $0.64 and low estimates of $0.58.
Analysts are recommending an EPS of between $2.5 and $2.32 for the fiscal current year, implying an average EPS of $2.35. EPS for the following year is $2.55, with 16.0 analysts recommending between $2.89 and $2.4.
Revenue Estimates
In the current quarter, 10 analysts expect revenue to total $525.72M. It ranges from a high estimate of $527.3M to a low estimate of $524M. As of the current estimate, Qiagen NV’s year-ago sales were $501.87MFor the next quarter, 10 analysts are estimating revenue of $540.13M. There is a high estimate of $547.6M for the next quarter, whereas the lowest estimate is $532.17M.
A total of 17 analysts have provided revenue estimates for QGEN’s current fiscal year. The highest revenue estimate was $2.18B, while the lowest revenue estimate was $2.04B, resulting in an average revenue estimate of $2.09B. In the same quarter a year ago, actual revenue was $1.98BBased on 17 analysts’ estimates, the company’s revenue will be $2.21B in the next fiscal year. The high estimate is $2.41B and the low estimate is $2.17B.
